Markus is an investment analyst focused on life science start-ups. His academic background as PhD in oncology provides him with a good understanding of the field. He has worked with scientific and business development in start-up companies and invested in a variety of early stage companies across various sectors as a business angel investor.
Markus holds a PhD with a focus in Oncology from the University of Oslo and a Master of Science in Molecular Medicine from NTNU Trondheim. He has published several articles in peer reviewed journals.